Position
Chief Executive Officer
Company
Neumirna Therapeutics
CopenhagenBiotechnologyHealth CareTherapeuticsPharmaceuticalDescription
Neumirna Therapeutics has appointed Ellen K. Donnelly, Ph.D., as their new Chief Executive Officer. With over 20 years of experience in neuroscience and rare diseases, she aims to lead the company’s transition into clinical development.
Quick answer
Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer (September 18, 2025). Neumirna Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.
- Who is the new Chief Executive Officer at Neumirna Therapeutics?
- Neumirna Therapeutics named Ellen K. Donnelly Chief Executive Officer, announced September 18, 2025.
- What did Neumirna Therapeutics announce on September 18, 2025?
- Neumirna Therapeutics has appointed Ellen K. Donnelly, Ph.D., as their new Chief Executive Officer. With over 20 years of experience in neuroscience and rare diseases, she aims to lead the company’s transition into clinical development.
- What does Neumirna Therapeutics do?
- Neumirna Therapeutics is a biotechnology company based in Copenhagen, Denmark, dedicated to developing RNA-based therapies for complex neurological diseases.
- Where is Neumirna Therapeutics based?
- Neumirna Therapeutics is based in Copenhagen, Capital Region Of Denmark, Denmark.
- Which similar companies made leadership changes around the same time?
- Parabilis Medicines (September 3, 2025), Pharming Group (September 2, 2025), Acadia Pharmaceuticals (August 26, 2025) and Atossa Therapeutics (October 14, 2025) also announced leadership changes within 45 days of Neumirna Therapeutics.
Source: Fundz verified event record.
Other recent leadership changes in Therapeutics and Pharmaceutical
Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.
- Parabilis Medicines Appoints Fawzi Benzaghou as Chief Medical Officer (September 3, 2025)
- Pharming Group N.V. Appoints Kenneth Lynard as Chief Financial Officer (September 2, 2025)
- Acadia Pharmaceuticals Appoints Konstantina Katcheves as Chief Business and Strategy Officer (August 26, 2025)
- Atossa Therapeutics Appoints Mark Daniel as Chief Financial Officer (October 14, 2025)
- Cantargia Appoints Dr Hilde Steineger as Chief Executive Officer (August 18, 2025)
- Kenox Pharmaceuticals Appoints Dr. Julianne Berry as Vice President of R&D and Manufacturing (October 21, 2025)
Who to call at Neumirna Therapeutics, and when
A new leader at Neumirna Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.
- An alert the day Neumirna Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Neumirna Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Neumirna Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Neumirna Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Neumirna Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.